| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 21.93% |
| INSM | INSMED INC | 3.19% |
| EYPT | EYEPOINT PHARMACEUTICALS | 2.55% |
| CYTK | CYTOKINETICS INC | 2.30% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 2.30% |
| PSNL | PERSONALIS | 2.29% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.22% |
| RVMD | REVOLUTION MEDICINES INC | 2.06% |
| DYN | DYNE THERAPEUTICS, INC. | 1.95% |
| TARS | TARSUS PHARMACEUTICALS | 1.93% |
| EWTX | EDGEWISE THERAPEUTICS | 1.85% |
| IMVT | IMMUNOVANT INC | 1.76% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.67% |
| PCVX | VAXCYTE INC | 1.63% |
| ARGX | ARGENX SE ADR | 1.62% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.55% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.54% |
| DNLI | DENALI THERAPEUTICS INC. | 1.49% |
| AKRO | AKERO THERAPEUTICS INC | 1.46% |
| HALO | HALOZYME THERAPEUTICS INC | 1.44% |
| ICLR | ICON PLC | 1.43% |
| AZN | ASTRAZENECA PLC-ADR | 1.42% |
| RGEN | REPLIGEN CORP | 1.42% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.40% |
| HCA | HCA HOLDINGS INC | 1.38% |
| THC | TENET HEALTHCARE CORP | 1.36% |
| MDT | MEDTRONIC PLC | 1.29% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.28% |
| ABBV | ABBVIE INC | 1.25% |
| DHR | DANAHER CORP | 1.25% |
| MCK | MCKESSON CORP | 1.24% |
| LENZ | LENZ THERAPEUTICS | 1.20% |
| GKOS | GLAUKOS CORPORATION | 1.18% |
| BDX | BECTON DICKINSON & CO | 1.14% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.14% |
| UNH | UNITEDHEALTH GROUP INC | 1.13% |
| REGN | REGENERON PHARMACEUTICALS | 1.10% |
| RMD | RESMED INC | 1.08% |
| HUM | HUMANA INC | 1.03% |
| ADMA | ADMA BIOLOGICS, INC. | 1.03% |
| ISRG | INTUITIVE SURGICAL INC | 1.02% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.02% |
| SNY | SANOFI- AVENTIS- ADR | 1.01% |
| SYK | STRYKER CORP | 1.00% |
| ABT | ABBOTT LABORATORIES | 1.00% |
| BSX | BOSTON SCIENTIFIC | 1.00% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 0.99% |
| VCEL | VERICEL CORP | 0.99% |
| TNDM | TANDEM DIABETES CARE INC | 0.96% |
| ALC | ALCON INC | 0.94% |
| ELV | ELEVANCE HEALTH INC | 0.92% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.82% |
| ZTS | ZOETIS INC | 0.80% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.79% |
| DXCM | DEXCOM INC | 0.77% |
| CDXS | CODEXIS INC | 0.74% |
| SPRY | ARS PHARMACEUTICALS | 0.74% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.62% |
| KRRO | KORRO BIO | 0.40% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.